LILLY FDA Approval NDA 050345

NDA 050345

LILLY

FDA Drug Application

Application #050345

Application Sponsors

NDA 050345LILLY

Marketing Status

Discontinued001

Application Products

001OINTMENT;TOPICAL0.05%;EQ 3.5MG BASE/GM0CORDRAN NFLURANDRENOLIDE; NEOMYCIN SULFATE

CDER Filings

cder:Array
(
    [0] => Array
        (
            [ApplNo] => 50345
            [companyName] => 
            [docInserts] => ["",""]
            [products] => []
            [labels] => 
            [originalApprovals] => []
            [supplements] => 
            [actionDate] => 0000-00-00
        )

)

© 2026 FDA.report
This site is not affiliated with or endorsed by the FDA.